Professor Zuguo Liu, Dean of our hospital, has been appointed to the Board of Directors of TFOS (Tear Film & Ocular Surface Society).

Our hospital was granted status as a Provincial-Level Model Development Site for High-Quality Advancement of Public Hospitals.

Two scientific achievements from our hospital secured international invention patent certificates, marking the institutions inaugural success in obtaining such global patents.

Our hospitals Tumor Subspecialty Program has officially launched its clinical services.

Professor Zuguo Liu, Dean of our hospital, was named to the 2022 Asia-Pacific Regions Top 100 Most Influential Ophthalmologists list.